Robin Shane Readnour Sells 35,402 Shares of Anthem (NASDAQ:ANTX) Stock

Anthem, Inc. (NASDAQ:ANTX – Get Free Report) Director Robin Shane Readnour sold 35,402 shares of the business’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $6.01, for a total transaction of $212,766.02. Following the completion of the transaction, the director owned 565,592 shares of the company’s stock, valued at $3,399,207.92. This trade represents a 5.89% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Anthem Stock Down 0.2%

NASDAQ:ANTX traded down $0.01 during trading hours on Wednesday, hitting $5.96. 266,091 shares of the stock were exchanged, compared to its average volume of 711,744. Anthem, Inc. has a twelve month low of $1.00 and a twelve month high of $7.19. The company has a market capitalization of $224.93 million, a P/E ratio of -5.57 and a beta of -0.99. The company’s 50 day moving average is $5.08 and its two-hundred day moving average is $3.92.

Get Anthem alerts:

Anthem (NASDAQ:ANTX – Get Free Report) last announced its quarterly earnings data on Tuesday, August 11th. The company reported ($0.18) EPS for the quarter.

Analyst Ratings Changes

A number of research analysts recently issued reports on ANTX shares. Wall Street Zen upgraded shares of Anthem from a “sell” rating to a “hold” rating in a report on Sunday, June 14th. Guggenheim started coverage on Anthem in a research report on Monday, July 20th. They issued a “buy” rating and a $9.00 target price on the stock. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Anthem in a research note on Monday, July 6th. Finally, Leerink Partners upgraded shares of Anthem from a “market perform” rating to an “outperform” rating and set a $9.00 price objective on the stock in a report on Thursday, May 14th. Two investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $9.00.

View Our Latest Analysis on ANTX

Hedge Funds Weigh In On Anthem

Hedge funds and other institutional investors have recently made changes to their positions in the company. Citizens Financial Group Inc. RI acquired a new position in Anthem during the second quarter worth $1,443,000. Seven Fleet Capital Management LP acquired a new stake in Anthem in the first quarter valued at $683,000. Vivo Capital LLC bought a new position in shares of Anthem in the 1st quarter valued at about $10,785,000. Bank of America Corp DE grew its position in shares of Anthem by 2.2% in the 1st quarter. Bank of America Corp DE now owns 393,702 shares of the company’s stock valued at $1,346,000 after acquiring an additional 8,390 shares during the period. Finally, Ally Bridge Group NY LLC bought a new position in shares of Anthem in the 1st quarter valued at about $1,800,000. 90.47% of the stock is owned by institutional investors.

About Anthem

(Get Free Report)

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products.

See Also

• Five stocks we like better than Anthem
• Bloom Energy’s AI Surge Meets a Valuation Reality Check
• Target Is Winning Shoppers Back—Can the Rally Reach $180?
• IonQ’s Space Contract Points to a New Frontier for Quantum Investors
• Is Apple’s AI Strategy Smarter Than Skeptics Think?

Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.